CD40L expression on CAR-T cells resulted in elevated surface expression of costimulatory molecules, adhesion molecules, HLA molecules and Fas death receptor on CD40+ tumor cells, thus increasing their immunogenicity [92]. The gene discussed is CD40; the disease is neoplasm.